| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/20/2008 | WO2008022153A3 Inhibitors of pde4 and methods of use |
| 11/20/2008 | WO2008021542A3 Lysine acteylation sites |
| 11/20/2008 | WO2008021415A3 Glycan data mining system |
| 11/20/2008 | WO2008019395A3 Compounds for improving learning and memory |
| 11/20/2008 | WO2008013985A3 Use of heat shock activators for tissue regeneration |
| 11/20/2008 | WO2008008264A3 Selective caspase inhibitors |
| 11/20/2008 | WO2007149938A3 Methods for promoting hair growth |
| 11/20/2008 | WO2007147106A3 Internal osseous delivery system and method |
| 11/20/2008 | WO2007143694A3 Macrocyclic oximyl hepatitis c protease inhibitors |
| 11/20/2008 | WO2007124354A3 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 11/20/2008 | WO2007115571A8 Erbb receptor-derived peptide fragments |
| 11/20/2008 | WO2007115131A3 Liposomal reduced glutathione and 1-arginine, including other ingredient(s) |
| 11/20/2008 | WO2007106597A3 Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia |
| 11/20/2008 | WO2007100902A3 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation |
| 11/20/2008 | WO2007097940A3 Reca inhibitors with antibiotic activity, compositions and methods of use |
| 11/20/2008 | WO2007094999A3 Ungual antifungal compositions |
| 11/20/2008 | WO2007087468A3 Adiponectin for treatment of various disorders |
| 11/20/2008 | WO2007076166A3 Methods of making modular fusion protein expression products |
| 11/20/2008 | WO2007075853A3 Protease compositions for the treatment of damaged tissue |
| 11/20/2008 | WO2007067753A3 Methods of reducing side effects in cancer therapy |
| 11/20/2008 | WO2007058968A3 Gene expression profiles and methods of use |
| 11/20/2008 | WO2007056083A3 Biosynthetic polypeptide fusion inhibitors |
| 11/20/2008 | WO2007018619A3 Chimeric therapeutic agents |
| 11/20/2008 | WO2006130429A3 Treatment of cancer |
| 11/20/2008 | WO2006096828A3 Chimeric proteins with phosphatidylserine binding domains |
| 11/20/2008 | WO2005089527A3 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores |
| 11/20/2008 | WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 11/20/2008 | WO2004030615A8 Compositions and methods for the diagnosis and treatment of tumor |
| 11/20/2008 | WO2003061577A8 Polyalkylene glycol with moiety for conjugating biologically active compound |
| 11/20/2008 | US20080289057 Sperm factor sequences |
| 11/20/2008 | US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 11/20/2008 | US20080288085 Vivo synthesis of connective tissues |
| 11/20/2008 | US20080287665 CANINE IgG NUCLEIC ACID MOLECULES |
| 11/20/2008 | US20080287659 G-CSF Conjugates |
| 11/20/2008 | US20080287545 Use of Peptide Compounds For the Prophylaxis and Treatment of Chronic Headache |
| 11/20/2008 | US20080287389 Nucleoside analogs in combination therapy of herpes simplex infections |
| 11/20/2008 | US20080287388 Human G-Protein Coupled Receptor |
| 11/20/2008 | US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 11/20/2008 | US20080287371 Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex |
| 11/20/2008 | US20080287370 Boronic Acid Salts Useful in Parenteral Formulations |
| 11/20/2008 | US20080287369 Compositions and Methods for Viscosupplementation |
| 11/20/2008 | US20080287368 Methods and Compositions For the Prevention and Treatment of Kidney Disease |
| 11/20/2008 | US20080287366 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 11/20/2008 | US20080287365 administering lactoferrin and the toll-like receptor ligand polyinosinic-polycytidylic acid to an animal |
| 11/20/2008 | US20080287364 Bitter Taste Receptors |
| 11/20/2008 | US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11 |
| 11/20/2008 | US20080287362 Compositions and Methods for the Detection of Trypanosoma Cruzi Infection |
| 11/20/2008 | US20080287361 Compositions and methods of using CRMP-1 and its fragments for treating cancer |
| 11/20/2008 | US20080287360 Administering an isolated peptide; variants, derivatives or structural equivalents of cupredoxins or cytochrome |
| 11/20/2008 | US20080287359 Cadherin-11-mediated modulation of hair growth |
| 11/20/2008 | US20080287358 Regulatory T Cell Mediator Proteins and Uses Thereof |
| 11/20/2008 | US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer |
| 11/20/2008 | US20080287356 Chimeric Proteins, Their Preparation and Pharmaceutical Compositions Containing Them |
| 11/20/2008 | US20080287355 Amylin and Amylin Agonists For Treating Psychiatric Diseases and Disorders |
| 11/20/2008 | US20080287354 Pure polypeptides, neural prosaposin receptor proteins; controlled release and liposome formulations; oral, topical, and injectable administration; Parkinson's and Alzheimer's Diseases, retinal neuropathy, amyotrophic lateral sclerosis |
| 11/20/2008 | US20080287353 Peptides and proteins for early liver development and antibodies thereto |
| 11/20/2008 | US20080287352 Anti-Histone H1 Monoclonal Antibody and Hybridoma for the Production Thereof |
| 11/20/2008 | US20080287351 Nfkb Transcriptional Activity Inhibitory Agent and Anti-Inflammatory Agent and a Steroid Action Enhancing Agent |
| 11/20/2008 | US20080287350 Aequorin-Containing Compositions and Methods of Using Same |
| 11/20/2008 | US20080287349 Fibroblast growth factor 20 and methods of use thereof |
| 11/20/2008 | US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies |
| 11/20/2008 | US20080287347 Novel Lipopeptides as Antibacterial Agents |
| 11/20/2008 | US20080287346 Bioactive peptides |
| 11/20/2008 | US20080287345 Polymyxin derivatives and uses thereof |
| 11/20/2008 | US20080287344 Use of Amino Acids for Making Medicines for Treating Insulin Resistance |
| 11/20/2008 | US20080287343 Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 11/20/2008 | US20080287342 Compositions Comprising Modified Collagen and Uses Therefor |
| 11/20/2008 | US20080287341 Treatment of vascular abnormalities using nanoparticles |
| 11/20/2008 | US20080286868 Metal binding compounds and their use in cell culture medium compositions |
| 11/20/2008 | US20080286828 Materials and methods relating to g-protein coupled receptor oligomers |
| 11/20/2008 | US20080286821 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/20/2008 | US20080286817 Novel allergens and treatment |
| 11/20/2008 | US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof |
| 11/20/2008 | US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
| 11/20/2008 | US20080286799 Methods of and kits and compositions for diagnosing colorectal tumors... |
| 11/20/2008 | US20080286381 biodrug comprising a nucleic acid sequence of nucleic acid; anticarcinogenic agents or antitumor agents; including cisplatin and carboplatin; effective chemotherapeutic agents in efficiency, being less invasive or toxic, and increased rate of recovery |
| 11/20/2008 | US20080286376 Dry hemostatic compositions and methods for their preparation |
| 11/20/2008 | US20080286375 capable of releasing a protein drug continuously over a long period of time without initial burst release; dissolving a protein drug in H2o to obtain a water phase; dissolving sucrose acetate isobutyrate and a biodegradable polymer in an organic solvent to obtain an oil phase, emulsifying |
| 11/20/2008 | US20080286372 Therapeutic compositions for targeted vessel delivery |
| 11/20/2008 | US20080286370 Nanoscale Particles Used as Contrasting Agents in Magnetic Resonance Imaging |
| 11/20/2008 | US20080286368 administered sublingually in combination with a bio/mucoadhesion promoting compound (e.g. hydroxypropyl cellulose) in a manner giving rise to pharmacologically effective plasma levels of zolpidam, morphine, sufentanyl etc.within a short time after administration to treat pain, insomnia, diabetes etc |
| 11/20/2008 | US20080286366 mammal blood platelet containing polyethyleneimine ( PEI) based nanoparticles (prepared by incubating PEI with green fluorescent protein (GFP) plasmid DNA) containing an active agent such as antibacterial, antiviral agent, blood coagulation protein, gene etc. drug delivery to sites of vascular injury |
| 11/20/2008 | US20080286361 deliverying a therapeutic agent (DNA, CFTR genes, peptide, antibody etc. ) contained in targeting particles (e.g. magnetite) to a cell using an electromagnet to apply a magnetic force so as to tend to move particles towards magnet and at the same time moving the magnet |
| 11/20/2008 | US20080286360 Chemically patterned hydrogels, manufacture and use thereof |
| 11/20/2008 | US20080286355 inhibitor of serine proteases(e.g.serpins, aprotinin, N-tosyl-L-phenylalanyl chloromethyl ketone, dichloroisocoumarin, nexin-1, AEBSF-HCl, Antipain, benzamidine, leupeptin, ovomucoid) ; amastatin, arphamenin, bestatin, diprotin A as metalloprotease inhibitor; irritable bowl syndrome; hyperalgesia |
| 11/20/2008 | US20080286347 Bioabsorbable synthetic nonwoven fabric holding thrombin |
| 11/20/2008 | US20080286339 Using multi-segment device to deliver selective androgen and estrogen receptor modulators to women in order to relieve symptoms associated with menopause |
| 11/20/2008 | US20080286338 Drug delivery system with scleral lens |
| 11/20/2008 | US20080286337 Method of treating a disease in an eye using a scleral lens |
| 11/20/2008 | US20080286329 Blood-derived plastic bone tissue articles; Young's Modulus of 0.03 GPa to 50 GPa; article; biological response modifiers hormones, growth factors, cytokines, extracellular matrix molecules; crosslinking agents iridoid derivatives, diimidates, diones; plasticizers phthalate, adipate, plant oils, glycols |
| 11/20/2008 | US20080286327 Thombolysis and chronic anticoagulation therapy |
| 11/20/2008 | US20080286323 Human Therapeutic Cells Secreting Nerve Growth Factor |
| 11/20/2008 | US20080286322 Methods and devices for the sustained release of multiple drugs |
| 11/20/2008 | US20080286309 Portion of SpaA protein is deleted for protection from Erysipelothrix rhusiopathiae infection; genetic engineering; Porcine erysipelas; high purity |
| 11/20/2008 | US20080286301 Treatment of diabetes |
| 11/20/2008 | US20080286293 Promiscuous pap cd4 t cell epitopes |
| 11/20/2008 | US20080286288 Vascular endothelial growth factor 2 |
| 11/20/2008 | US20080286287 Methods and Agents for Modulating Cellular Activity |
| 11/20/2008 | US20080286285 Methods for Treating Vascular Disease |
| 11/20/2008 | US20080286284 Compositions of PSMA antibodies |